Shandong Xinhua Pharmaceutical Company Limited (HKG:0719)

Market Cap	8.93B
Revenue (ttm)	9.23B
Net Income (ttm)	496.91M
Shares Out	689.78M
EPS (ttm)	0.72
PE Ratio	7.83
Forward PE	n/a
Dividend	0.05 (0.95%)
Ex-Dividend Date	Sep 4, 2024

Volume	1,686,000
Average Volume	2,472,812
Open	5.62
Previous Close	5.62
Day's Range	5.60 - 5.70
52-Week Range	5.00 - 8.05
Beta	0.02
RSI	44.23
Earnings Date	Mar 31, 2025

About HKG:0719

Shandong Xinhua Pharmaceutical Company Limited develops, manufactures, and sells bulk pharmaceuticals, preparations, and chemical products in the People’s Republic of China, the Americas, Europe, and internationally. It offers antipyretic and analgesic, cardiovascular and cerebrovascular, anti-infective, and central nervous drugs under the Xinhua brand; and contract manufacturing services for active pharmaceutical ingredients and pharmaceutical intermediates, OTC, and generics. The company also provides ibuprofen bulk pharmaceutical products; a...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1943
• Employees: 7,104
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 0719

Financial Performance

In 2023, HKG:0719's revenue was 8.10 billion, an increase of 7.97% compared to the previous year's 7.50 billion. Earnings were 496.51 million, an increase of 20.79%.

Financial numbers in CNY